戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              FANCG has been shown to contain seven tetratricopeptide
2                                              FANCG interacted with one of these regions and specifica
3                                              FANCG is a part of the FA core complex that is responsib
4                                              FANCG(S7A) aberrantly localized to globules in chromatin
5 ANCC (3), FANCD1 (1), FANCD2 (3), FANCF (2), FANCG (2), FANCI (1), FANCJ (2), and FANCL (3).
6                       S387A mutant abolished FANCG fusion protein phosphorylation by cdc2.
7 recipitated with BRCA2 from human cells, and FANCG co-localized in nuclear foci with both BRCA2 and R
8                                    FANCA and FANCG are dispensable for maximal in vitro ubiquitinatio
9                  Here we show that FANCA and FANCG are redox-sensitive proteins that are multimerized
10 interaction studies indicated that FANCA and FANCG bind directly to mu-calpain.
11 multimerization and interaction of FANCA and FANCG in vitro.
12 triggers the multimeric complex of FANCA and FANCG in vivo but also induces the interaction between F
13                                The FANCA and FANCG proteins deficient in FA groups A and G interact d
14                               Both FANCA and FANCG proteins exist as monomers under non-oxidizing con
15 current study, mutant forms of the FANCA and FANCG proteins have been generated and analyzed with res
16     Similar immunolocalization for FANCA and FANCG suggested that these proteins interact in vivo.
17 r results lead us to conclude that FANCA and FANCG uniquely respond to oxidative damage by forming co
18                       All exons of FANCA and FANCG were sequenced, and no mutations were found.
19    We find that both the upstream (FANCA and FANCG) and downstream (FANCD2) FA pathway components pro
20 the other cloned FA gene products (FANCA and FANCG) remain unknown.
21 n of FANCA restored levels of both FANCA and FANCG, whereas overexpression of FANCG or FANCC did not
22 tween the localization patterns of FANCA and FANCG.
23 so induces the interaction between FANCA and FANCG.
24 ker interaction of FANCE with both FANCA and FANCG.
25           Human cells deficient in FANCC and FANCG are also hypersensitive to plasma levels of formal
26                                    FANCC and FANCG disruption abrogated FANCD2 monoubiquitination, co
27                                    FANCC and FANCG disruption also resulted in increased clastogenic
28  interstrand-cross-linking agents, FANCC and FANCG disruption caused increased clastogenic damage, G2
29                           Finally, FANCC and FANCG disruption increased spontaneous chromosomal break
30          We endogenously disrupted FANCC and FANCG in a human adenocarcinoma cell line and determined
31       The recent identification of FANCC and FANCG mutations in resected pancreatic tumors selected f
32 To further assess the relevance of FANCC and FANCG mutations to pancreatic cancer we conducted a muta
33 inherited and somatic mutations of FANCC and FANCG present in young-onset pancreatic cancer.
34  its effector RAD51 and the FANCA, FANCC and FANCG proteins.
35 ently, several sequence changes in FANCC and FANCG were reported in pancreatic cancer.
36  coimmunoprecipitates with FANCA, FANCC, and FANCG but not with FANCD2.
37 rescent-tagged versions of FANCA, FANCC, and FANCG colocalize in cytoplasm and nucleus, chiefly in ch
38                 Given that FANCA, FANCC, and FANCG complementation groups account for more than 90% o
39 BM cells, mutations in the FANCA, FANCC, and FANCG genes markedly increase the amount of PKR bound to
40 d cross-links and that the FANCA, FANCC, and FANCG proteins are bound to this damaged DNA as well.
41 minimally dependent on the FANCA, FANCC, and FANCG proteins, does not require FANCD2.
42 al interaction of at least FANCA, FANCC, and FANCG, and possibly of other FA and non-FA proteins.
43 ow that three FA proteins, FANCA, FANCC, and FANCG, functionally interact with the PKR kinase, which
44 he Fanconi anemia proteins FANCA, FANCC, and FANCG.
45 3 of the encoded proteins, FANCA, FANCC, and FANCG/XRCC9, interact in a multisubunit protein complex.
46 e of the encoded proteins, FANCA, FANCC, and FANCG/XRCC9, interact in a nuclear complex, required for
47 emia (FANCA, FANCC, FANCD2, FANCE, FANCF and FANCG) as well as BRCA1 and BRCA2 (FANCD1).
48 o determine whether FANCA, FANCC, FANCF, and FANCG directly interact with ERCC1 and XPF and, if so, t
49 plex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FAN
50 cts (FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG proteins) interact in a common pathway.
51 nes (FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG).
52 uding FRA1, ETV4, MCM2, AXL, MT3, TRAP1, and FANCG), whereas 36 genes (including IGFBP3, TRAM1, and K
53 , there were high-confidence LoF variants at FANCG and CASP8 in two patients accompanied by somatic l
54                         This binding between FANCG and the ERCC1-XPF endonuclease, combined with our
55 ved C-terminal site in BRCA2 that also binds FANCG/XRCC9.
56 arboxy-terminal leucine zipper region, bound FANCG in the cytoplasm.
57 ort, we demonstrate that the recently cloned FANCG/XRCC9 protein is required for binding of the FANCA
58     The molecular mass of cytoplasmic FANCA, FANCG, FANCC, and nuclear FANCD2 were normal.
59 Fanconi anaemia genes include FANCD2, FANCA, FANCG, ERCC4, FANCE and FANCI, while DNA mismatch repair
60 xhibited a marked decrease in nuclear FANCA, FANCG, and FANCD2-L.
61         These results demonstrate that FANCA-FANCG complexes are required for cellular resistance to
62 toplasm, we suggest that FANCC and the FANCA-FANCG complexes suppress MMC cytotoxicity within distinc
63 G complementary DNA (cDNA) resulted in FANCA/FANCG binding, prolongation of the cellular half-life of
64 On the basis of 2-hybrid analysis, the FANCA/FANCG binding is a direct protein-protein interaction.
65     These results demonstrate that the FANCA/FANCG interaction is required to maintain the cellular l
66                                FANCA, FANCC, FANCG, and FANCF proteins form a multisubunit nuclear co
67 FA-binding proteins, including FANCA, FANCC, FANCG, cdc2, and GRP94, thus validating the approach.
68 elected mutations in DNA repair genes FANCC, FANCG and BRCA2 respectively, were less sensitive to MK-
69 crete complex comprising FANCD1/BRCA2-FANCD2-FANCG-XRCC3 (D1-D2-G-X3).
70 ificantly reduced MMC sensitivity but FANCF, FANCG, and FANCC did not.
71 proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) form a nuclear Fanconi anemia core comp
72  The FA proteins FANCA, FANCC, FANCE, FANCF, FANCG, and FANCL participate in a core complex.
73  FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL), and identified orthologs in the genom
74  FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM, and FANCN).
75 that the amino terminal two-thirds of FANCG (FANCG amino acids 1-428) binds to the amino terminal nuc
76  region of the FANCA protein is required for FANCG binding, FANCC binding, nuclear localization, and
77                                 Furthermore, FANCG could be co-immunoprecipitated with BRCA2 from hum
78          We demonstrate that the FA group G (FANCG) protein is found in mitochondria.
79 er, Fanconi anemia complementation group G- (FANCG-) and FANCC-deficient pancreatic tumor lines were
80 he in vivo role of one of these human genes (FANCG), we generated a targeted disruption of murine Fan
81                                        Human FANCG complemented these cells, whereas human FANCG(S7A)
82 ANCG complemented these cells, whereas human FANCG(S7A) did not.
83               Phosphorylation of serine 7 in FANCG is functionally important in the FA pathway.
84                   The site of interaction in FANCG was mapped to a motif that binds to SH3 domains an
85 rrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G.
86          Eight of the FA proteins, including FANCG, participate in a nuclear core complex that is req
87  expression of FANCA mutants encoding intact FANCG interaction domains induced hypersensitivity to MM
88 n of FANCA was abolished by mutations in its FANCG-binding domain.
89               Wild-type but not G546R mutant FANCG physically interacts with the mitochondrial peroxi
90     A characteristic matching of FANCC-null, FANCG-null, BRCA2/FANCD1-null, and PALB2/FANCN-null phen
91 ot sufficient for the functional activity of FANCG.
92              We propose that this binding of FANCG to alphaIISp may be important for the stability of
93 PRs 1, 3, 5, and 6 are needed for binding of FANCG to ERCC1.
94 r, these results demonstrate that binding of FANCG to the amino terminal FANCA NLS sequence is necess
95 current study the functional consequences of FANCG/FANCA binding were examined.
96 o noncontiguous carboxyl-terminal domains of FANCG encompassing amino acids 400-475 and 585-622.
97 n human and hamster cells that expression of FANCG protein, but not the other core complex proteins,
98           Moreover, at least one function of FANCG and FANCA is to regulate the nuclear accumulation
99  a 14-kDa fragment of the C-terminal half of FANCG.
100 we show that loss of the murine homologue of FANCG (Fancg) results in a defect in MSPC proliferation
101          Mapping the sites of interaction of FANCG with ERCC1, using site-directed mutagenesis, demon
102 th a reciprocal increase in the half-life of FANCG.
103 h FANCA and FANCG, whereas overexpression of FANCG or FANCC did not restore FANCA levels.
104 83 and S387 abolished the phosphorylation of FANCG at mitosis.
105                       The phosphorylation of FANCG at serine 7 by using mass spectrometry was previou
106         We also show that phosphorylation of FANCG serine 7 is required for its co-precipitation with
107 tudy was to map the phosphorylation sites of FANCG at mitosis and to assess their functional importan
108 no acid sequences at the carboxy terminus of FANCG are required for the binding of FANCC in the compl
109 strate that the amino terminal two-thirds of FANCG (FANCG amino acids 1-428) binds to the amino termi
110  clastogenic damage on irradiation, but only FANCG disruption caused a subsequent decrease in relativ
111 tion events for core complex member proteins FANCG and FANCA by phosphorylation.
112 lts demonstrate that one of the FA proteins, FANCG, contains a motif that interacts directly with the
113                    One of these FA proteins, FANCG, was found to have a strong affinity for ERCC1 and
114  We show that in an in vitro kinase reaction FANCG is radioactively labeled.
115 lls that fail to express either phospho-Ser7-FANCG, or full length BRCA2 protein, lack the interactio
116                     These results argue that FANCG has a role independent of the FA core complex, and
117 epair (HRR) is supported by our finding that FANCG and the RAD51-paralog XRCC3 are epistatic for sens
118                                We found that FANCG was capable of binding to two separate sites in th
119 ed with our previous studies which show that FANCG is involved in the incision step mediated by ERCC1
120 ion sequence (NLS) of FANCA, suggesting that FANCG plays a role in regulating FANCA nuclear accumulat
121                                          The FANCG protein binds directly to the amino terminal nucle
122 cates that FA patients with mutations in the FANCG gene and patients homozygous for null mutations in
123                                Moreover, the FANCG protein is a component of a nuclear protein comple
124 nterestingly, a truncated mutant form of the FANCG protein, lacking the carboxy terminus, binds in a
125 ch is associated with phosphorylation of the FANCG protein.
126         We and others have reported that the FANCG protein (Fanconi complementation group G) is phosp
127  in Chinese hamster ovary cells in which the FANCG homologue is mutant.
128     Correction of an FA-G cell line with the FANCG complementary DNA (cDNA) resulted in FANCA/FANCG b
129 lu(7) appeared to be critical for binding to FANCG.
130 the previously described binding of FANCA to FANCG, we now demonstrate direct interaction of FANCF wi
131 ve candidate tumor suppressor genes (TOPORS, FANCG, RAD51, TP53BP1, and BIK) that could have a role i
132 truncating FANCC mutations but no truncating FANCG mutations were identified in young onset (<55 year
133                               Only wild-type FANCG cDNA fully corrected FA-G mutant cells.
134 We also tested the effect of human wild-type FANCG in Chinese hamster ovary cells in which the FANCG
135                                Unexpectedly, FANCG(S7A) bound to and stabilized the endogenous forms
136                     The FA pathway, of which FANCG is a part, is highly regulated by a series of phos
137 demonstrate direct interaction of FANCF with FANCG, of FANCC with FANCE and a weaker interaction of F
138   ERCC1, in turn, was shown to interact with FANCG via its central domain, which is different from th

 
Page Top